Virus

History

Virology

Ethnology

Ebola virus

Virus diseases

Marburg virus

New guinea

Medicine

New England Journal of Medicine

single mutants (i.e., BA.2_L452Q and BA.2_ S704L) had neutralizing-antibody escape that was similar to that of the BA.4/5 and BA.2.12.1 subvariants, with neutralizing-antibody titers that were 14.1% and 26.6% lower, respectively, than those against BA.2 (P>0.05 for both comparisons) (Fig. 1D).Notably, 2 of 30 BA.1-infected but unvaccinated patients (Patients U12 and U13) had high neutralizing-antibody titers against all the variants except BA.4/5, whereas patients who had received a booster dose had broader neutralization against all the variants examined (Fig. S3C andS3D).Overall, these results showed that infection during the BA.1 wave did not appear to offer effective protection against the newly emerged sublineages.In this study, we characterized infectioninduced immunity and vaccine-induced immunity against newly emerged omicron subvariants.Booster vaccination provided sufficient neutralizing-antibody titers against the BA.4/5 and BA.2.12.1 subvariants, albeit to a lower extent than against BA.1 and BA.2. 4,5These findings underscore the importance of booster vaccination for protection against emerging variants.

Detection of Marburg Virus Disease in Guinea